Funding in the biotech model from conception through maturity

08/5/2008 | Scientist, The (free registration)

Biotech companies today tend to develop intellectual property and then license or sell it, rather than focusing on an end-stage commercial product. IPOs and venture capital funding for early-stage research have declined in recent years, but pharmaceutical companies increasingly are buying small biotechs' early-stage work to supplement their own pipelines. This analysis looks at the overlay between drug development and the financial life cycle of a biotech firm.

View Full Article in:

Scientist, The (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC